BLOOD PRODUCTS TRANSFUSION DURING 2012-13 IN PESHAWAR, PAKISTAN

Rashid Azeem, Nadia Altaf, Syed Humayun Shah, Naeem Khattack, Muhammad Tariq Masood Khan, Muhammad Tahir

Abstract


Background: Blood products transfusion has been a major treatment modality especially in critical care settings. The objectives of this study were to determine frequency and distribution of blood products transfusion in public and private health care facilities during 2012-2013 in Peshawar, Pakistan.
Materials & Methods: This cross-sectional, study was conducted in the Department of Pathology, Northwest School of Medicine, Peshawar, Pakistan from 1st January 2012 to 31st December 2013. Sample size was 2,04,942 blood products transfusion, selected through consecutive non probability technique. All allogeneic cases of transfusions in inpatient and emergency were included. A total of six public, one private and two stand-alone blood banks were enrolled into the study. Demographic variable were name of the health care facility, sex and age groups of donors. Research variables were type of blood products transfusion (whole blood, packed red blood cell, fresh frozen plasma, platelets). All variables being categorical were described as count and percentages. Data was analyzed using software SPSS version 23.
Results: Out of 2,04,942 units, 1,33,212 (65%) were men and 71,730 (35%) women. Packed red blood cells were the most commonly used component with 80227 units (39.1%), whole blood 77655 units (37.8%), Fresh frozen plasma 35932 units (17.5%) and platelets 11128 units (5.6%). Blood products transfusion was 46927 units (22.89%) in <12 years, 20847 units (10.17%) in 12-17 years, 55492 units (27.07%) in 18-40 years, 51516 units (25.13%) in 41-64 years and 30160 units (14.71%) in >65 years.
Conclusion: Modal group was men. Packed red blood cells were the most frequently transfused blood component in hospitals of Peshawar especially Lady reading hospital. Most common age group was 18-40 years. Whole blood still comprises a significant fraction of transfusions which is alarming.

Keywords


Utilization; Blood; Components.

Full Text:

PDF

References


Ramani KV, Mavalankar DV, Govil D. Study of blood transfusion services in Maharastra and Gujarat states, India. J Health Popul Nutr 2009;27:259-7.

World Health organization. Blood safety: situation analysis [online] 2008. [cited 2018 Jan 25] Available from URL: http://www.emro.who.int/pakistan/programmeareas_bloodsafety.html

World Health organization. World blood donor day, Pakistan [online] 2008. [cited 2018 June 16] Available from URL : http://www.who.int/worldblooddonorday/archives/2006/wbdd_pakistan/en/index.html

Bhagwat SN, Sharma JH. A retrospective audit of appropriateness and monitoring of fresh frozen plasma transfusions in a tertiary care hospital. Inte J Contemp Med Res 2017;4:1562-7.

Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Hematol 2004;126:11-28.

Madrigal E, Prajapati S, Avadhani V, Annen K, Friedman MT. Adequacy of physician documentation and correlation with assessment of transfusion appropriateness: a follow-up study in the setting of prospective audits and patient blood management. Transfus 2017;57:367-75.

Friedman MT, Ebrahim A. Adequacy of physician documentation of red blood cell transfusion and correlation with assessment of transfusion appropriateness. Arch Pathol Lab Med 2006;130;474-9.

Goncalez TT, Sabino EC, Capuani L, Liu J, Wright DJ, Walsh JH, et al. Blood transfusion utilization and recipient survival at hospital das clinicas in Sao Paulo, Brazil. Transfus 2012;52:729-38.

Sharma DC, Tripathi L, Woike P, Rai S, Gaur R. Audit of platelet usage among patients: A descriptive study of various platelet concentrates. Int Blood Res Rev 2016;6:1-9.

Afzal S. A comparison of public and private hospital on rational use of blood in Islamabad. J Pak Med Assoc 2013;63;85-9.

Iqbal H, Bhatti FA, Salamat N, Akhtar F, Hafeez K. A Clinical audit of fresh frozen plasma usage. J Rawalpindi Med Coll 2013;17:122-4.

Ambroise MM, Ravichandran K, Ramdas A, Sekhar G. A study of blood utilization in a tertiary care hospital in South India. J Nat Sci Biol Med 2015;6:106-10.

Borkent-Raven BA, Janssen MP, Van der Poel CL, Schaasberg WP, Bonsel GJ, Van HoutBA.The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang 2010;99:55-64.

Bosch MA, Contreras E, Madoz P, Ortiz P, Pereira A, Pujol MM. The epidemiology of blood component transfusion in Catalonia, Northeastern Spain. Transfus 2012;51:105-16.

Tiwari AK, Ratan A, Arora D, Aggarwal G, Mehta SB, Setya D, et al. Audit of clinical use of red blood cells in a tertiary care setting: an algorithmic approach. Glob J Transfus Med 2017;2:109-12.

Bansod PN, Jethani N, Pachori G. Clinical use of blood and its components in tertiary health care center in northwestern India. Int J Med Sci Public Health 2015;4:787-91.

Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med 2007;17:1-15.

Mirzamani N, Molana A, Poorani E. Evaluation of appropriate usage of fresh frozen plasma: Results of a regional audit in Iran. Transfus Apher Sci 2009;40:109-13.

Yeh CJ, Wu CF, Hsu WT, Hsieh LL, Lin SF, Liu TC. Transfusion of fresh frozen plasma in southern Taiwan. Vox Sang 2006;91:270-4.

Raosoft® sample size calculator. Seattle, WA, USA: Raosoft Inc.; 2004. [cited 2015 Sep 22] Available at: http://www.raosoft.com/samplesize.html


Refbacks

  • There are currently no refbacks.


© 2011 Gomal Journal of Medical Sciences